Microbiome metabolomics reveals new drivers of human liver steatosis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.Frontiers in cellular and infection microbiology · 2022
   Trial
2. Nutrients · 2025
   Article
3. The Roles of Myeloid Cells in Aging-related Liver Diseases.International journal of biological sciences · 2023
   Review
4. Plasma Metabolomic and Lipidomic Profiling of Metabolic Dysfunction-Associated Fatty Liver Disease in Humans Using an Untargeted Multiplatform Approach.Metabolites · 2022
   Article
5. Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis.World journal of hepatology · 2022
   Review
6. Optimization of metabolomic data processing using NOREVA.Nature protocols · 2022
   Review
7. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role ofFrontiers in medicine · 2022
   Review
8. Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices.Nature methods · 2021
   Review
9. Roles of Gut Microbial Metabolites in Diabetic Kidney Disease.Frontiers in endocrinology · 2021
   Review
10. Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism.Science advances · 2020
    Article
11. The Role of the Gut Microbiota in Lipid and Lipoprotein Metabolism.Journal of clinical medicine · 2019
    Review
12. Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome.Signal transduction and targeted therapy
    Review

Corrections and comments

• Comment on
  Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women.2018

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as